৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Products
Payment
Delivery
Dyslipidemia, Hypertriglyceridaemin, Prophylaxis of myocardial infarction
Should be taken with food.
Oral\r\nHypertriglyceridaemia\r\nAdult: 4 g once daily 2g twice daily.\r\n\r\nSecondary prophylaxis of myocardial infarction\r\nAdult: 1 g daily.
<18 years: Safety and efficacy not established\r\n\r\n
Patients with known hypersensitivity (e.g., anaphylactic reaction) to LOVAZA or any of its components.
The omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid are long-chain n-3 polyunsaturated fatty acids, which compete with arachidonic acid for inclusion in cyclo-oxygenase and lipoxygenase pathways. Their actions include hypolipidaemic action (especially a reduction in plasma triglycerides) by reducing very-low-density lipoproteins; anti-inflammatory action, attributed to effects on leukotriene synthesis; and antiplatelet effect, attributed to effects on prostanoid synthesis, which promote vasodilatation, reduction in platelet aggregation, increased bleeding time and decreased platelet counts.
Haemorrhagic disorders or those receiving anticoagulants or other drugs that have antithrombotic activity; asthmatic patients sensitive to aspirin. Monitor hepatic function in patients with hepatic impairment, especially if receiving high doses.\r\n\r\nLactation: Not known if excreted in breast milk; use caution
1-10%\r\nEructation (4.9%),Infection (4.4%),Flu-like syndrome (3.5%),Dyspepsia (3.1%),Taste perversion (2.7%),Back pain (2.2%),Pain (1.8%),Rash (1.8%),Angina pectoris (1.3%)
Dyslipidemia, Hypertriglyceridaemin, Prophylaxis of myocardial infarction
Should be taken with food.
Oral\r\nHypertriglyceridaemia\r\nAdult: 4 g once daily 2g twice daily.\r\n\r\nSecondary prophylaxis of myocardial infarction\r\nAdult: 1 g daily.
<18 years: Safety and efficacy not established\r\n\r\n
Patients with known hypersensitivity (e.g., anaphylactic reaction) to LOVAZA or any of its components.
The omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid are long-chain n-3 polyunsaturated fatty acids, which compete with arachidonic acid for inclusion in cyclo-oxygenase and lipoxygenase pathways. Their actions include hypolipidaemic action (especially a reduction in plasma triglycerides) by reducing very-low-density lipoproteins; anti-inflammatory action, attributed to effects on leukotriene synthesis; and antiplatelet effect, attributed to effects on prostanoid synthesis, which promote vasodilatation, reduction in platelet aggregation, increased bleeding time and decreased platelet counts.
Haemorrhagic disorders or those receiving anticoagulants or other drugs that have antithrombotic activity; asthmatic patients sensitive to aspirin. Monitor hepatic function in patients with hepatic impairment, especially if receiving high doses.\r\n\r\nLactation: Not known if excreted in breast milk; use caution
1-10%\r\nEructation (4.9%),Infection (4.4%),Flu-like syndrome (3.5%),Dyspepsia (3.1%),Taste perversion (2.7%),Back pain (2.2%),Pain (1.8%),Rash (1.8%),Angina pectoris (1.3%)





N/A



